Evolva Holding SA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Evolva Holding SA with three other
miscellaneous service companies in Europe:
sales of 11.20 million Euro [US$12.18 million]
of which 100%
was Royalty Income),
Circassia Pharmaceuticals PLC
of the United Kingdom
(£10.80 million [US$13.15 million]
of which 95%
was operating-NIOX), and
based in Italy
(13.58 million Euro [US$14.77 million]
Evolva Holding SA reported sales of 13.36 million Swiss Francs (US$13.50 million)
December of 2015.
increase of 24.4%
versus 2014, when the company's sales were 10.74 million Swiss Francs.
This was the third consecutive year of growth at Evolva Holding SA.